Table 1.

Clinical Characteristics of Patients

	Baseline	No.
Age	<65 years	31
	≥65 years	17
Gender	Male	34
	Female	14
Smoking	Never	23
	Current/ever	25
BMI	<18.5	2
	≥18.5 to <25	23
	≥25	23
PS	0–1	33
	2	15
CCI	0	19
	1–2	13
	≥3	16
ALB (g/dL)	<4.13	23
	≥4.13	25
WBC (×109/L)	<6.47	23
	≥6.47	25
RBC (×1012/L)	<4.30	15
	≥4.30	33
PLT (×109/L)	<231.50	24
	≥231.50	24
MONO (×109/L)	<0.38	31
	≥0.38	17
EO (×109/L)	<0.12	28
	≥0.12	20
BASO (×109/L)	<0.05	38
	≥0.05	10
NLR	<2.08	20
	≥2.08	28
LMR	<10.86	46
	≥10.86	2
PLR	<124.27	22
	≥124.27	26
Pro-GRP	Normal	3
	High	21
NSE	Normal	28
	High	20
Postoperative chemotherapy	Yes	33
	No	15

Abbreviations: BMI, body mass index; PS, performance status; CCI, Charlson comorbidity index; ALB, albumin count; WBC, white blood cell count; RBC, red blood cell count; PLT, platelet count; MONO, monocyte count; EO, eosinophil count; BASO, basophil count; NLR, neutrophil to lymphocyte ratio; LMR, lymphocyte to monocyte ratio; PLR, platelet to lymphocyte ratio; ALI, advanced lung cancer inflammation index; CEA, carcinoembryonic antigen; LDH, lactate dehydrogenase; SCC, squamous cell carcinoma antigen; CYFRA 21-1, cytokeratin-19 fragment; Pro-DRP, pro-gastrin releasing peptide; NSE, neuron-specific enolase; CRP, C-reactive protein.